References
- Babic, A.M., Kirreva, M.L., Kolesnikova, T.V., and Lau, L.F., (1998). CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 95, 6355-6360. https://doi.org/10.1073/pnas.95.11.6355
- Bakin, A.V., Tomlinson, A.K., Bhowmick, N.A., Moses, H.L., and Arteaga, C.L., (2000). Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275, 36803-36810. https://doi.org/10.1074/jbc.M005912200
- Barker, H.E., Chang, J., Cox, T.R., Lang, G., Bird, D., Nicolau, M., Evans, H.R., Gartland, A., and Erler, J.T., (2011). LOXL2-mediated matrix remodeling in metastasis and mammary gland involution. Cancer Res. 71, 1561-1572. https://doi.org/10.1158/0008-5472.CAN-10-2868
- Boble, B.W., and Woodgett, J.R., (2007). Role of glycogen synthase kinase-3 in cell fate and epithelial-mesenchymal transitions. Cells Tissues Organs 185, 73-84. https://doi.org/10.1159/000101306
- Chen, C.H., Huang, L.L., Huang, C.C., Lin, C.C., Lee, Y., and Lu, F.J., (2000). Baicalein, a novel apoptotic agent for hepatoma cell lines: a potential medicine for hepatoma. Nutr. Cancer 38, 287-295. https://doi.org/10.1207/S15327914NC382_19
- Christofori, G., (2006). New signals from the invasive front. Nature 441, 444-450. https://doi.org/10.1038/nature04872
- Chuang, J.Y., Yu, N.Y., Chiang, I.P., Lai, C.H., Lin, C.D., and Tang, C.H., (2012). Cyr61 increases matrix metalloproteinase-3 expression and cell motility in human oral squamous cell carcinoma cells. J. Cell Biochem. 113, 1977-1986. https://doi.org/10.1002/jcb.24066
-
Chung, H., Choi, H.S., Seo, E.K., Kang, D.H., and Oh, E.S., (2015). Baicalin and baicalein inhibit transforming growth factor-
${\beta}1$ - mediated epithelial-mesenchymal transition in human breast epithelial cells. Biochem. Biophys. Res. Commun. 458, 707-713. https://doi.org/10.1016/j.bbrc.2015.02.032 - De Craene, B., Van Roy, F., and Berx, G., (2005). Unraveling signaling cascades for the Snail family of transcription factors. Cell. Signal. 17, 535-547. https://doi.org/10.1016/j.cellsig.2004.10.011
- Dominguez, D., Montserrat-Sentis, B., Virgos-Soler, A., Guaita, S., Grueso, J., Porta, M., Puig, I., Baulida, J., Franci, C., and Garcia de Herreros, A., (2003). Phosphorylation regulates the subcellular location and activity of the snail transcriptional repressor. Mol. Cell. Biol. 23, 5078-5089. https://doi.org/10.1128/MCB.23.14.5078-5089.2003
- Fox, J.T., Sakamuru, S., Huang, R., Teneva, N., Simmons, S.O., Xia, M., Tice, R.R., Austin, C.P., Myung, K., (2012). Highthroughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death. Proc. Natl. Acad. Sci. USA 109, 5423-5428. https://doi.org/10.1073/pnas.1114278109
- Grezeszkiewiz, T.M., Linder, V., Chen, N., Lam, S.C., and Lau, L.F., (2002). The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulate chemotaxis through integrin alpha(6)beta(1) and cell surface heparin sulfate proteoglycans. Endocrinology 143, 1441-1450. https://doi.org/10.1210/endo.143.4.8731
- Grille, S.J., Bellacosa, A., Upson, J., Klein-Szanto, A.J., van Roy, F., Lee-Kwon, W., Donowitz, M., Tsichlis, P.N., and Larue, L., (2003). The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res. 63, 2172-2178.
- Haque, I., Mehta, S., Majumder, M., Dhar, K., De, A., McGregor, D., Van Veldhuizen, P.J., Banerjee, S.K., and Banerjee, S., (2011). Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis. Mol. Cancer 10, 8-25. https://doi.org/10.1186/1476-4598-10-8
- Hayashi, K., Fong, K.S., Mercier, F., Boyd, C.D., Csiszar, K., and Hayashi, M., (2004). Comparative immunocytochemical localization of lysyl oxidase (LOX) and the lysyl oxidase-like (LOXL) proteins: changes in the expression of LOXL during development and growth of mouse tissues. J. Mol. Histol. 35, 845-855. https://doi.org/10.1007/s10735-004-2340-1
- Hou, C.H., Lin, F.L., Hou, S.M., and Liu, J.F., (2014). Cyr61 promotes epithelial-mesenchymal transition and tumour metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway. Mol. Cancer 13, 236-249. https://doi.org/10.1186/1476-4598-13-236
- Janicke, R.U., (2009). MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res. Treat. 117, 219-221. https://doi.org/10.1007/s10549-008-0217-9
- Julien, S., Puig, I., Caretti, E., Bonaventure, J., Nelles, L., van Roy, F., Dargemont, C., de Herreros, A.G., Bellacosa, A., and Larue, L., (2007). Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchymal transition. Oncogene 26, 7445-7456. https://doi.org/10.1038/sj.onc.1210546
- Kirschmann, D.A., Seftor, E.A., Fong, S.F., Nieva, D.R., Sullivan, C.M., Edwards, E.M., Sommer, P., Csiszar, K., and Hendrix, M.J., (2002). A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res. 62, 4478-4483.
- Kuo, H.M., Tsai, H.C., Lin, Y.L., Yang, J.S., Huang, A.C., Yang, M.D., Hsu, S.C., Chung, M.C., Gibson Wood, W., and Chung, J.G., (2009). Mitochondrial-dependent caspase activation pathway is involved in baicalein-induced apoptosis in human hepatoma J5 cells. Int. J. Oncol. 35, 717-724.
-
Lee, K.B., Byun, H.J., Park, S.H., Park, C.Y., Lee, S.H., and Rho, S.B., (2012). CYR61 controls p53 and NF-
${\kappa}B$ expression through PI3K/Akt/mTOR pathways in carboplatin-induced ovarian cancer cells. Cancer Lett. 315, 86-95. https://doi.org/10.1016/j.canlet.2011.10.016 - Lin, M.T., Zuon, C.Y., Chang, C.C., Chen, S.T., Chen, C.P., Lin, B.R., Wang, M.Y., Jeng, Y.M., Chang, K.J., Lee, P.H., et al. (2005). Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway. Clin. Cancer Res. 11, 5809-5820. https://doi.org/10.1158/1078-0432.CCR-04-2639
- Li-Weber, M., (2009). New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat. Rev. 35, 57-68. https://doi.org/10.1016/j.ctrv.2008.09.005
-
Ma, X., Yan, W., Dai, Z., Gao, X., Ma, Y., Xu, Q., Jiang, J., and Zhang, S., (2016). Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/
${\beta}$ -catenin pathway. Drug Des. Devel. Ther. 10, 1419-1441. - Moreno-Bueno, G., Salvador, F., Martin, A., Floristan, A., Cuevas, E.P., Santos, V., Montes, A., Morales, S., Castilla, M.A., Rojo-Sebastián, A., et al. (2011). Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas. EMBO Mol. Med. 3, 528-544. https://doi.org/10.1002/emmm.201100156
- Nieto, M.A., (2002). The snail superfamily of zinc-finger transcription factors. Nat. Rev. Mol. Cell Biol. 3, 155-166. https://doi.org/10.1038/nrm757
- Peinado, H., Del Carmen Iglesias-de la Cruz, M., Olmeda, D., Csiszar, K., Fong, K.S., Vega, S., Nieto, M.A., Cano, A., and Portillo, F., (2005). A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. EMBO J. 24, 3446-3458. https://doi.org/10.1038/sj.emboj.7600781
- Peinado, H., Moreno-Bueno, G., Hardisson, D., Perez-Gomez, E., Santos, V., Mendiola, M., de Diego, J.I., Nistal, M., Quintanilla, M., Portillo, F., et al. (2008). Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas. Cancer Res. 68, 4541-4550. https://doi.org/10.1158/0008-5472.CAN-07-6345
- Po, L.S., Chen, Z.Y., Tsang, D.S., and Leung, L.K., (2002). Baicalein and genistein display differential actions on estrogen receptor (ER) transactivation and apoptosis in MCF-7 cells. Cancer Lett. 187, 33-40. https://doi.org/10.1016/S0304-3835(02)00355-5
- Tan, T.W., Yang, W.H., Lin, Y.T., Hsu, S.F., Li, T.M., Kao, S.T., Chen, W.C., Fong, Y.C., and Tang, C.H., (2009). Cyr61 increases migration and MMP-13 expression via alphavbeta3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cells. Carcinogenesis 30, 258-268. https://doi.org/10.1093/carcin/bgn284
- Tran, T.A., Krishnamoorty, K., Cho, S.K., and Kim, S.J., (2016). Inhibitory effect of zinc sulfide nanoparticles towards breast cancer stem cell migration and invasion. J. Biomed. Nanotechnol. 12, 329-336. https://doi.org/10.1166/jbn.2016.2187
- Wang, Y., and Zhou, B.P., (2001). Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin. J. Cancer 30, 603-611.
- Wang, L., Ling, Y., Chen, Y., Li, C.L., Feng, F., You, Q.D., Lu, N., and Guo, Q.L. (2010). Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. Cancer Lett. 297, 42-48. https://doi.org/10.1016/j.canlet.2010.04.022
- Wu, B., Li, J., Huang, D., Wang, W., Chen, Y., Liao, Y., Xiaowei, T., Hongfu, X., and Faqing, T., (2011). Baicalein mediates inhibition of migration and invasiveness of skin carcinoma through Ezrin in A431 cells. BMC Cancer 11, 527-35. https://doi.org/10.1186/1471-2407-11-527
- Xie, D., Nakachi, K., Wang, H., Elashoff, R., and Koeffler, H.P., (2001). Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res. 61, 8917-8923.
- Zhang, F., Phiel, C.J., Spece, L., Gurvich, N., and Klein, P.S., (2003). The Akt-glycogen synthase kinase 3beta pathway regulates transcription of atrial natriuretic factor induced by betaadrenergic receptor stimulation in cardiac myocytes. J. Biol. Chem. 278, 33067-33077. https://doi.org/10.1074/jbc.M212635200
- Zhou, B.P., Deng, J., Xia, W., Xu, J., Li, Y.M., Gunduz, M., and Hung, M.C., (2004). Dual regulation of Snail by GSK-3betamediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol. 6, 931-940. https://doi.org/10.1038/ncb1173
Cited by
- Biotransformation of Chrysin to Baicalein: Selective C6-Hydroxylation of 5,7-Dihydroxyflavone Using Whole Yeast Cells Stably Expressing Human CYP1A1 Enzyme vol.65, pp.34, 2017, https://doi.org/10.1021/acs.jafc.7b02690
- Polymorphisms of the CYR61 gene in patients with acute myeloid leukemia in a Han Chinese population vol.97, pp.34, 2018, https://doi.org/10.1097/MD.0000000000011963
- Lysyl Oxidase–like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer vol.77, pp.21, 2016, https://doi.org/10.1158/0008-5472.can-16-3152
- Quantitative Proteomics Implicates Rictor/mTORC2 in Cell Adhesion vol.17, pp.10, 2018, https://doi.org/10.1021/acs.jproteome.8b00218
- Baicalein suppresses non small cell lung cancer cell proliferation, invasion and Notch signaling pathway vol.22, pp.1, 2018, https://doi.org/10.3233/cbm-170673
- Transition from normal to cancerous cell by precancerous niche (PCN) induced chronic cell-matrix stress vol.2, pp.None, 2019, https://doi.org/10.1051/fopen/2018996
- USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma vol.9, pp.2, 2016, https://doi.org/10.7150/thno.27654
- Controlling metastatic cancer: the role of phytochemicals in cell signaling vol.145, pp.5, 2016, https://doi.org/10.1007/s00432-019-02892-5
- Structural Insight into the In Vitro Anti-Intravasative Properties of Flavonoids vol.87, pp.3, 2016, https://doi.org/10.3390/scipharm87030023
- Honokiol inhibits breast cancer cell metastasis by blocking EMT through modulation of Snail/Slug protein translation vol.40, pp.9, 2016, https://doi.org/10.1038/s41401-019-0240-x
- KRas-ERK signalling promotes the onset and maintenance of uveal melanoma through regulating JMJD6-mediated H2A.X phosphorylation at tyrosine 39 vol.47, pp.1, 2016, https://doi.org/10.1080/21691401.2019.1673764
- Baicalein enhances the antitumor efficacy of docetaxel on nonsmall cell lung cancer in a β‐catenin‐dependent manner vol.34, pp.1, 2016, https://doi.org/10.1002/ptr.6501
- The interaction between cucurbit[8]uril and baicalein and the effect on baicalein properties vol.16, pp.None, 2020, https://doi.org/10.3762/bjoc.16.9
- Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy vol.215, pp.None, 2016, https://doi.org/10.1016/j.pharmthera.2020.107633